% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

  • reeves0527 reeves0527 Aug 5, 2011 6:04 PM Flag

    Well know Biotech Analyst Jason Napodano

    today tweeted that NBIX is a great long term play. This was his quote.

    JNapodanoJason Napodano, CFA

    $NBIX at $6.68 is a great long-term play. Elagolix is a blockbuster drug, they have a ton of cash, and $ABT as a commercial partner.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Thanks for posting

      There are a significant number of value creating pipeline events over the next 18 months.

      Two event that are on my radar for FY12 is VMAT2 (NBI-96854) moving into a P1 trial for schizophrenia a blockbuster indication for this program and a P2 read-out for Tardive Dyskinesia. NBIX only plans to partner this drug outside of North America, thus keeping U.S. rights.

44.56-0.22(-0.49%)12:22 PMEDT